Joseph A Odin - Liver Transplantation | Mount Sinai

Biography

Specialties

Liver Transplantation

Research

Dr. Odin's liver research focuses on Autoimmune Liver Disease, Toxicity, Fatty Liver Disease, and Viral Hepatitis. Clinical trials and studies are being conducted or planned for primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune hepatitis, drug or toxin induced liver injury, hepatitis B and C, and non-alcoholic fatty liver disease. Some of the research is investigator initiated while other studies are supported by the National Institutes of Health or Pharmaceutical Companies. Please go to Programs in Autoimmune Liver Diseases.

Education

AB, Cornell University

PhD, C.U.N.Y.

MD, Icahn School of Medicine at Mount Sinai

Residency, Internal Medicine, Mount Sinai Hospital

Fellowship, Gastroenterology, Johns Hopkins University School of Medicine-Gastro

Certifications

American Board of Internal Medicine

Honors & Awards

2007

Solomon Silver Award for Clinical Research

2003

Research Excellence in GI and Liver Disease Award

Publications

59

Publications

Selected Publications

Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury. Dina Halegoua-DeMarzio, Victor J. Navarro, Ashley Davis, Jawad Ahmad, Bharathi Avula, Huiman Barnhart, A. Sidney Barritt, Herbert L. Bonkovsky, Vincent L. Chen, Gina Choi, Robert J. Fontana, Marwan S. Ghabril, Ikhlas Khan, Christopher Koh, Joseph Odin, Don C. Rockey, Hoss Rostami, Jose Serrano, Averell H. Sherker, Andrew Stolz, Hans L. Tillmann, Raj Vuppalanchi. Drug Safety

Clinical characteristics and HLA associations of azithromycin-induced liver injury. Caroline Conlon, Yi Ju Li, Jawad Ahmad, Huiman Barnhart, Robert J. Fontana, Marwan Ghabril, Paul H. Hayashi, David E. Kleiner, William M. Lee, Victor Navarro, Joseph A. Odin, Elizabeth J. Phillips, Andrew Stolz, Raj Vuppalanchi, Dina Halegoua-DeMarzio. Alimentary Pharmacology and Therapeutics

Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Robert J. Fontana, Yi Ju Li, Vincent Chen, David Kleiner, Andrew Stolz, Joe Odin, Raj Vuppalanchi, Jiezhun Gu, Lily Dara, Huiman Barnhart. Hepatology Communications

View All Publications

Office Locations

Icahn (East) Building Floor 4 Room 4-89

1425 Madison Ave

New York, NY 10029

212-289-7738

Icahn (East) Building Floor 4th floor Room 4-89

1425 Madison Ave

New York, NY 10029

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Odin has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Odin has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.